← Eichor
Condition: Methylphenidate Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Methylphenidate

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
Phase 4 · 4 location(s) · Icahn School of Medicine at Mount Sinai · NCT03781752Pharmacogenomics of Stimulant Treatment Response
Phase N/A · 1 location(s) · University of Calgary · NCT06221358Attention Deficit Hyperactivity Disorder
NA · 3 location(s) · Nantes University Hospital · NCT06232226Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints
Phase 4 · 3 location(s) · VA Office of Research and Development · NCT05776056Benefits of ADHD Treatment in Detained People
Phase 3 · 1 location(s) · Stéphanie Baggio · NCT05842330Efficacy of Reboxetine and Methylphenidate Treatment on Attentional, Sensory and Emotional Dysregulation in Adults With
Phase 2 · 3 location(s) · University of Haifa · NCT05133804An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jo
Phase 4 · 1 location(s) · NYU Langone Health · NCT06577779Metabolic Mechanisms of the Electrophysiological Biomarkers for Response to Methylphenidate Treatment in Children With A
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT06073470Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder
Phase 4 · 1 location(s) · Hospital de Clinicas de Porto Alegre · NCT02951754Lisdexamphetamine Vs Methylphenidate for Pediatric Patients with ADHD and Type 1 Diabetes
Phase 2 · 1 location(s) · Medical University of Lodz · NCT05957055Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue
Phase 3 · 4 location(s) · Odense University Hospital · NCT06905587MEthylphenidate in ADHD - Addiction(s) Comorbidity: Value of Adding a Cognitive Remediation Program to Improve Short- an
NA · 6 location(s) · Nantes University Hospital · NCT06906328Assessing Real Life Effectiveness of Treatment in Neurodevelopmental Disorders
Phase N/A · 1 location(s) · IRCCS Eugenio Medea · NCT07273695Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
Phase 4 · 4 location(s) · VA Office of Research and Development · NCT04419272Methylphenidate in KBG Syndrome: N-of-1 Series
Phase 4 · 1 location(s) · Radboud University Medical Center · NCT06465641Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Phase 4 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT03781765Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia
Phase 2 · 1 location(s) · Sunnybrook Health Sciences Centre · NCT07279740Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
Phase 1 · 1 location(s) · St. Jude Children's Research Hospital · NCT07226219EEG-MRI Imaging of Methylphenidate Effects in Adult ADHD and Attentional Symptoms in Mood Disorders
Phase 3 · 1 location(s) · University Hospital, Strasbourg, France · NCT05832489Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD
Phase 4 · 1 location(s) · Johns Hopkins University · NCT04781972Medication Treatment of ADHD in Pediatric Epilepsy
Phase 4 · 1 location(s) · Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · NCT07594652
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.